Expert review committee for key considerations for developing and integrating patient perspectives in drug development: Examination of the Duchenne case study

Holly Peay

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept

Expert review committee for key considerations for developing and integrating patient perspectives in drug development

Examination of the Duchenne case study

Peay, H. (2016). Expert review committee for key considerations for developing and integrating patient perspectives in drug development: Examination of the Duchenne case study. BIO.

Copy citation

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults

Article

Use of a web-based portal to return normal individual research results in Early Check

Article

The importance of quality data to track global progress in addressing stillbirths and neonatal mortality

Article

Expert review committee for key considerations for developing and integrating patient perspectives in drug development

Publications Info

Recent Publications

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults

Use of a web-based portal to return normal individual research results in Early Check

The importance of quality data to track global progress in addressing stillbirths and neonatal mortality

Pre-natal exposure to NO2 and PM2.5 and newborn lung function

Partner With Us

Site